Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lucid Diagnostics (LUCD) Change in Account Payables (2022 - 2025)

Historic Change in Account Payables for Lucid Diagnostics (LUCD) over the last 4 years, with Q3 2025 value amounting to -$82000.0.

  • Lucid Diagnostics' Change in Account Payables fell 13519.31% to -$82000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$384000.0, marking a year-over-year decrease of 37234.04%. This contributed to the annual value of $96000.0 for FY2024, which is 786.52% up from last year.
  • As of Q3 2025, Lucid Diagnostics' Change in Account Payables stood at -$82000.0, which was down 13519.31% from $4000.0 recorded in Q2 2025.
  • Over the past 5 years, Lucid Diagnostics' Change in Account Payables peaked at $2.0 million during Q1 2022, and registered a low of -$1.3 million during Q3 2022.
  • In the last 4 years, Lucid Diagnostics' Change in Account Payables had a median value of -$57000.0 in 2022 and averaged -$50000.0.
  • In the last 5 years, Lucid Diagnostics' Change in Account Payables skyrocketed by 36491.23% in 2023 and then crashed by 65833.33% in 2024.
  • Over the past 4 years, Lucid Diagnostics' Change in Account Payables (Quarter) stood at -$57000.0 in 2022, then skyrocketed by 364.91% to $151000.0 in 2023, then dropped by 29.8% to $106000.0 in 2024, then tumbled by 177.36% to -$82000.0 in 2025.
  • Its Change in Account Payables was -$82000.0 in Q3 2025, compared to $4000.0 in Q2 2025 and -$412000.0 in Q1 2025.